Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.07%
1,101.37
-0.81
-0.07%
1,102.181,096.241,103.051,090.35
SIXC
Communications
SIXC
Communications
SIXC
-0.47%
613.35
-2.89
-0.47%
616.24616.24617.68609.10
SIXE
Energy
SIXE
Energy
SIXE
+0.77%
1,198.83
+9.11
+0.77%
1,189.721,194.741,202.791,188.58
SIXI
Industrials
SIXI
Industrials
SIXI
+1.75%
1,755.95
+30.26
+1.75%
1,725.691,730.021,762.991,730.02
SIXM
Financials
SIXM
Financials
SIXM
-0.79%
638.51
-5.11
-0.79%
643.62643.13643.17632.59
SIXR
Staples
SIXR
Staples
SIXR
+1.65%
843.52
+13.73
+1.65%
829.79832.32845.25832.32
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.19%
215.95
+2.55
+1.19%
213.40213.40216.07213.40
SIXT
Technology
SIXT
Technology
SIXT
-1.48%
3,138.91
-47.01
-1.48%
3,185.923,160.893,178.723,102.60
SIXU
Utilities
SIXU
Utilities
SIXU
+2.80%
934.37
+25.43
+2.80%
908.94912.57934.91912.57
SIXV
Health care
SIXV
Health care
SIXV
-0.10%
1,477.43
-1.53
-0.10%
1,478.961,478.171,482.911,466.65
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.05%
2,380.19
-25.17
-1.05%
2,405.362,390.342,402.532,359.18
600276:SHA
Jiangsu Hengrui Pharmaceuticals Co Ltd
CN¥56.05
-0.62%
(-0.35) 1D
Apr 24, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600276...
Open
CN¥56.50
High
CN¥56.75
Low
CN¥55.32
Mkt. cap
353.65B
Avg. vol.
56.93M
Volume
55.78M
P/E ratio
45.50
52-wk high
CN¥74.04
52-wk low
CN¥48.88
EPS
CN¥1.23
Shares outstanding
3.68B
No. of employees
21K
News stories
From sources across the web
Profile
Jiangsu Hengrui Pharmaceuticals Company Ltd., also known as Jiangsu Hengrui, is a Chinese pharmaceutical company that manufactures and distributes various types of drug packaging materials, cancer-treating antineoplastics, cardiovascular medication, painkillers, antibiotics, and related products. It is the largest listed pharmaceutical company in China. Wikipedia
About Jiangsu Hengrui Pharmaceuticals Co Ltd
CEO-
Employees20.6K
FoundedApr 28, 1997
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
8.56B
7.43B
8.44B
8.14B
Cost of goods sold
1.06B
1.07B
1.25B
1.09B
Cost of revenue
1.06B
1.07B
1.25B
1.09B
Research and development expenses
1.69B
1.72B
2.02B
1.65B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.12B
3.23B
3.01B
2.81B
Operating expense
4.88B
4.76B
5.35B
4.47B
Total operating expenses
5.93B
5.83B
6.60B
5.56B
Operating income
2.62B
1.60B
1.84B
2.58B
Other non operating income
-11.50M
-154.21M
145.74M
-83.27M
EBT including unusual items
2.98B
1.36B
2.30B
2.56B
EBT excluding unusual items
2.79B
1.68B
1.91B
2.50B
Income tax expense
397.10M
55.51M
338.85M
275.87M
Effective tax rate
13.35%
4.08%
14.76%
10.79%
Other operating expenses
59.00M
-217.30M
326.84M
4.76M
Net income
2.58B
1.30B
1.96B
2.28B
Net profit margin
30.11%
17.52%
23.22%
28.04%
Earnings per share
-
0.20
-
-
Interest and investment income
177.52M
242.14M
288.66M
-
Interest expense
-738.84K
-689.68K
-2.00M
-
Net interest expenses
176.78M
241.45M
286.66M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
2.82B
1.78B
2.04B
2.78B
Gain or loss from assets sale
-2.31M
2.31M
-4.05M
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more